NYSE:SYK - Stryker Stock Price, Forecast & News

Stryker's stock was trading at $175.62 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SYK shares have decreased by 14.8% and is now trading at $149.58. View which stocks have been mosted impacted by Coronavirus.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 1 sell rating, 6 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker.

Stryker is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for Stryker.

Stryker Co. (NYSE:SYK) issued its quarterly earnings data on Tuesday, January, 28th. The medical technology company reported $2.49 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.46 by $0.03. The medical technology company earned $4.13 billion during the quarter, compared to analysts' expectations of $4.11 billion. Stryker had a net margin of 13.99% and a return on equity of 25.75%. The business's revenue was up 8.8% on a year-over-year basis. During the same period last year, the company posted $2.18 EPS. View Stryker's earnings history.

Stryker declared a quarterly dividend on Friday, February 7th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.575 per share on Thursday, April 30th. This represents a $2.30 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date is Monday, March 30th. View Stryker's dividend history.

Stryker updated its FY20 earnings guidance on Tuesday, January, 28th. The company provided earnings per share (EPS) guidance of $9.00-9.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.04.

22 brokers have issued 1-year price objectives for Stryker's stock. Their forecasts range from $145.00 to $248.00. On average, they expect Stryker's share price to reach $211.10 in the next twelve months. This suggests a possible upside of 41.1% from the stock's current price. View analysts' price targets for Stryker.

News stories about SYK stock have trended very negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Stryker earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave press coverage about the medical technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutStryker.

Stryker saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 5,538,700 shares, an increase of 43.9% from the February 27th total of 3,850,000 shares. Based on an average trading volume of 1,640,000 shares, the short-interest ratio is currently 3.4 days. Approximately 1.6% of the shares of the stock are short sold. View Stryker's Current Options Chain.

Some companies that are related to Stryker include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Insulet (PODD), Masimo (MASI) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Medtronic (MDT), Visa (V), AbbVie (ABBV), Home Depot (HD), Boeing (BA), NVIDIA (NVDA), Bank of America (BAC) and QUALCOMM (QCOM).

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include CWS Financial Advisors LLC (0.08%), Bath Savings Trust Co (0.02%), McGuire Investment Group LLC (0.02%), First Financial Bank Trust Division (0.01%), Cullinan Associates Inc. (0.01%) and M&R Capital Management Inc. (0.00%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker. View institutional ownership trends for Stryker.

SYK stock was sold by a variety of institutional investors in the last quarter, including CWS Financial Advisors LLC, and M&R Capital Management Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Srikant M Datar, and Timothy J Scannell. View insider buying and selling activity for Stryker.

SYK stock was bought by a variety of institutional investors in the last quarter, including Cullinan Associates Inc., Bath Savings Trust Co, First Financial Bank Trust Division, and McGuire Investment Group LLC. View insider buying and selling activity for Stryker.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $149.58.

Stryker has a market capitalization of $56.07 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe. View additional information about Stryker.

The official website for Stryker is http://www.strykercorp.com/.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]